Humana (HUM) reported $29.12 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 13.2%. EPS of -$2.16 for the same period compares to -$0.11 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $28.82 billion, representing a surprise of +1.05%. The company delivered an EPS surprise of +4.42%, with the consensus EPS estimate being -$2.26.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall St ...

SAN DIEGO, Feb. 11, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of Humana Inc. (NYSE: HUM).Investors who purchased shares of Humana Inc. (NYSE: HUM) prior to July 2022 and continue to hold any of thoseNYSE: HUM shares have also certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.In June 2024, an investor inNYSE: HUM shares filed a lawsuit against Humana Inc ...

Humana Tuesday reported $1.2 billion in 2024 profits that included a $693 million fourth quarter ... [+] loss as the health insurer exits unprofitable Medicare Advantage markets for 2025, the company disclosed Feb. 11, 2025. In this photo is a Humana office in Louisville, Kentucky, US, on Monday, July 31, 2023. (Photographer: Jon Cherry/Bloomberg)© 2023 Bloomberg Finance LPHumana Tuesday reported $1.2 billion in 2024 profits that included a $693 million fourth quarter loss as the health insurer exits unprof ...

Health insurance company Humana HUM is set to release its fourth-quarter 2024 earnings report on Feb. 11, before market hours. The stock has dropped 2.37% from the previous close, as of writing, on Feb.10, according to Benzinga Pro. The stock is up 5.58% year-to-date but has fallen 27.73% in the past year.In the previous quarter, Humana reported revenues of $29.4 billion — a 15.2% year-over-year increase. It surpassed analysts’ expectations by 2.6%. The company also achieved a solid beat on earnings per sha ...

Humana Inc. (HUM) is scheduled to release fourth-quarter 2024 results on Feb. 11, before the opening bell. The Zacks Consensus Estimate for earnings is pegged at a loss of $2.26 per share, wider than the prior-year quarter’s loss of 11 cents per share.  See the Zacks Earnings Calendar to stay ahead of market-making news.The fourth-quarter earnings estimate has witnessed one downward revision over the past 30 days. Meanwhile, the Zacks Consensus Estimate for revenues is pegged at $28.8 billion, indicating 12 ...

Analysts on Wall Street project that Humana (HUM) will announce quarterly loss of $2.26 per share in its forthcoming report, representing a decline of 1954.6% year over year. Revenues are projected to reach $28.82 billion, increasing 12% from the same quarter last year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.7% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before ...

New York, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Sword Health, an AI health company making world-class, life-changing care accessible anytime, anywhere, today announced the appointment of Bruce Broussard, former CEO of Humana, as a board advisor. Broussard’s extensive experience in healthcare innovation and leadership further strengthens Sword Health’s mission to free the world from pain.  “Bruce’s visionary leadership and unwavering commitment to advancing healthcare accessibility and outcomes make him an inva ...

Humana (HUM) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on February 11. On ...

Humana (HUM) shares rallied 3.1% in the last trading session to close at $293.80. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 11.5% gain over the past four weeks.This marks the fourth consecutive day of Humana’s price increases. Increased optimism related to an uptick in Medicare Advantage plan payments for 2026, which would amount to over $21 billion in additional funds for insurers and favorable earning ...

Talicia is now covered by Humana's Part D Plan, providing access to Talicia for H. pylori therapy to more than eight million additional Medicare lives, without requiring prior therapeutic steps or authorizationThe recently updated American College of Gastroenterology (ACG) Clinical Guideline lists Talicia as a first-line option for treatment of H. pylori infection. Talicia continues to be the most prescribed branded H. pylori therapy by U.S. gastroenterologistsAdditionally, new data describing the foundatio ...